Generisys

GeneriSys helps pharmacies, manufacturers, healthcare investors, and global pharmaceutical traders understand and control drug procurement pathways. Large multi-billion dollar pharmacies use GeneriSys to negotiate and obtain the optimal wholesaler agreement, benchmarked to their peers and competitors. Then, GeneriSys promotes opportunistic tactics to access direct generic contracts, GPO and Distributor agreements, and Fee-for-Service manufacturer programs. Manufacturers use GeneriSys to gain connectivity to the end-use pharmacy, and to develop collaborative programs that will impact market share. GeneriSys provides innovative turnkey solutions for direct-to-pharmacy sales, Limited Distribution Networks, launching niche products, and payer positioning strategies. Healthcare investors use GeneriSys to quantify the target pharmacy's cost-of-goods profile, to validate excellence and to identify opportunities. GeneriSys connects buyers and sellers, supports the M&A process during due diligence, and helps attain incremental improvements in purchasing after the transaction closes. Global traders use GeneriSys to source generic, brand, and OTC drugs for emerging international markets. GeneriSys brings the supplier and the buyer together for the exchange of 100% pedigreed products that are in high demand in fast-growing economies. With the vision of "Generics for America; and Brands for the World", we have our finger on the “pulse of possibility”.